← Eichor
Condition: Healthy Volunteer Male Subjects Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Healthy Volunteer Male Subjects

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
NA · 1 location(s) · Scott Silveira · NCT07144527To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
Phase 1 · 1 location(s) · Prestige Biopharma Limited · NCT05108259A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Phase 1/Phase 2 · 7 location(s) · Rhythm Pharmaceuticals, Inc. · NCT06239116A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insuffici
Phase 1 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07001436Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)
NA · 1 location(s) · The Methodist Hospital Research Institute · NCT06664827Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults
Phase 1 · 2 location(s) · Haiphong University of Medicine and Pharmacy · NCT07060209To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects
Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT07013773Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions
Phase 1 · 2 location(s) · Haiphong University of Medicine and Pharmacy · NCT07032558Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepati
Phase 1 · 2 location(s) · Atea Pharmaceuticals, Inc. · NCT06911320Clinical Trials of IBI3035 in Healthy Subjects
Phase 1 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07591519Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject
Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT06935721Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions
Phase 1 · 1 location(s) · AJU Pharm Co., Ltd. · NCT07643220A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Phase 1 · 1 location(s) · Hansoh BioMedical R&D Company · NCT05942625A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®
Phase 1 · 1 location(s) · Berlin-Chemie AG Menarini Group · NCT07156916A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects
Phase 1 · 1 location(s) · Staidson (Beijing) Biopharmaceuticals Co., Ltd · NCT06948799Near-InfraRed Spectroscopy of Auricular Stimulation
NA · 1 location(s) · University of Pittsburgh · NCT06825364The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer
EARLY_Phase 1 · 1 location(s) · FindCure Biosciences (ZhongShan) Co., Ltd. · NCT07468708A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subj
Phase 1 · 1 location(s) · Inventage Lab., Inc. · NCT05620940Urinary Vitamin C Loss in Diabetic Subjects
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00071526Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects
Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT06935682A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects
Phase 1 · 1 location(s) · Addpharma Inc. · NCT07444385
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.